Regeneron to Offer Prescriptions at Most Favored Prices
President Trump announced today that Regeneron has agreed to offer its prescriptions at most favored nation prices. The deal aims to lower costs for patients.
Xurve View
Xurve View
In a significant development for domestic pharmaceutical pricing, President Donald Trump announced on Thursday that a major drug manufacturer has committed to a new pricing structure. According to the President, Regeneron Pharmaceuticals has agreed to offer its prescriptions at prices aligned with the most favored nation status.
